Tuftsin

Overview

Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) that corresponds to residues 289–292 of the CH2 domain of the immunoglobulin G (IgG) heavy chain. It was discovered in 1970 by Victor Najjar and colleagues at Tufts University School of Medicine — whence the name — as the active phagocytosis-stimulating factor released from IgG by two sequential enzymatic cleavages.

The biological significance of tuftsin lies in its role as a "hidden" immune signal generated from circulating antibodies. Native IgG does not exhibit tuftsin activity; the tetrapeptide must first be released by the enzyme leukokininase (at the Arg-Glu bond) in the spleen, followed by carboxypeptidase action, yielding the free tetrapeptide. This arrangement couples tuftsin activity to antibody turnover and splenic processing, effectively gating the signal through a checkpoint that is compromised in splenectomized patients.

Tuftsin stimulates phagocytic activity of macrophages, monocytes, and neutrophils; enhances antigen presentation; and modulates cytokine production. The peptide has been extensively studied as a template for developing immunomodulatory analogs, most notably selank — a stabilized tuftsin analog used in Russian neuropsychopharmacology research — and the peptide rigin, a related IgG-derived sequence.

Structure/Sequence

Sequence: Thr-Lys-Pro-Arg (TKPR)

• Length: 4 amino acids (tetrapeptide)
• Molecular weight: ~501 g/mol
• Source: IgG heavy chain CH2 domain (residues 289–292 in human IgG1 numbering)
• Charge: Highly basic (Lys and Arg)
• Proline: Imparts conformational constraint at position 3

The sequence is highly conserved across mammalian IgG subclasses, though the precise release efficiency differs. Tuftsin is inactive when buried in the intact Fc domain; only the free tetrapeptide is biologically active.

Biosynthesis

1. Leukokininase (a splenic enzyme) cleaves the Arg-Glu bond at position 292–293 of the IgG heavy chain
2. Carboxypeptidase-like activity then liberates the free tetrapeptide
3. Tuftsin is released into circulation where it can act on phagocyte targets

Mechanism of Action

Receptor Binding

A specific tuftsin receptor was identified as neuropilin-1 (NRP1) in 2013, resolving a long-standing question in the field. NRP1 is a transmembrane protein expressed on:

• Macrophages and monocytes
• Microglia
• T regulatory cells (Tregs)
• Certain endothelial cells

Binding to NRP1 initiates downstream signaling including PI3K/Akt and modulation of Treg function.

Phagocytic Stimulation

• Enhances phagocytic activity of macrophages toward opsonized and non-opsonized particles
• Increases neutrophil chemotaxis
• Boosts monocyte bactericidal activity
• Augments respiratory burst and reactive oxygen species production in response to targets

Cytokine Modulation

• Promotes IL-1, IL-6, TNF-α secretion from stimulated macrophages (context-dependent)
• Enhances IL-2 production in T cells
• Modulates antigen presentation via effects on dendritic cells

Anti-Inflammatory Aspects

Paradoxically, tuftsin can also induce anti-inflammatory macrophage polarization in some contexts and has been shown to ameliorate experimental autoimmune encephalomyelitis in animal models by promoting M2 macrophage phenotype. The dual pro- and anti-inflammatory effects suggest context-dependent signaling.

Tuftsin Deficiency

Classical tuftsin deficiency was described in splenectomized patients and in certain congenital conditions. The clinical phenotype — increased susceptibility to encapsulated bacterial infection — parallels post-splenectomy sepsis risk and highlights the spleen's role as the production site.

Research Summary

Common Discussion Topics

1. "Hidden" antibody signal — Tuftsin is a paradigmatic example of a cryptic bioactive peptide embedded in a larger protein. Its release requires specific enzymatic processing, creating a two-step check on activation. Many other cryptic peptides have been identified since, including angiotensin-(1-7) and casomorphin.

2. Splenic dependency — The spleen is required for tuftsin production. Post-splenectomy immunodeficiency involves multiple mechanisms, but reduced tuftsin generation is one contributing factor to the well-known susceptibility to encapsulated bacterial organisms.

3. Neuropilin-1 receptor — NRP1 is more commonly known as a semaphorin and VEGF co-receptor. Its role as a tuftsin receptor adds an immunological dimension to NRP1 biology and has implications for the design of therapeutics targeting this receptor.

4. Selank and stabilization — Native tuftsin has a short plasma half-life due to peptidase cleavage. Substituting Pro-Gly-Pro onto the C-terminus yields selank (TKPRPGP), which is markedly more stable and has been studied for anxiolytic and nootropic properties.

5. Dual-edge immunomodulation — Tuftsin can both enhance innate immune responses to pathogens and promote regulatory/anti-inflammatory responses in autoimmune contexts. Understanding which signals tilt the balance is a central research question.

Related Compounds

• Selank — tuftsin-derived heptapeptide with extended half-life
• Defensins — innate immune antimicrobial peptides
• Thymulin — zinc-dependent thymic nonapeptide
• Thymosin Alpha-1 — thymic immunomodulatory peptide